1
|
Aschenborn O, Aschenborn J, Kern P, Mackenstedt U, Romig T, Wassermann M. When wildlife comes to town: interaction of sylvatic and domestic host animals in transmission of Echinococcus spp. in Namibia. Helminthologia 2023; 60:117-124. [PMID: 37745225 PMCID: PMC10516471 DOI: 10.2478/helm-2023-0012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2023] [Accepted: 05/29/2023] [Indexed: 09/26/2023] Open
Abstract
The present study was conducted in the isolated desert town of Oranjemund in the far south of Namibia. It is an extremely arid region where no livestock husbandry is practiced and only animals adapted to the desert can be found. However, in and around the city, artificial irrigation maintains lush green patches of grass that attract wild animals, in particular oryx antelopes (Oryx gazella). In 2015 four oryx antelopes were euthanised due to poor conditions and a post-mortem examination was conducted. Two were found positive for cystic echinococcosis and 16 cysts were collected for molecular analyses. In addition, faecal samples from black-backed jackals (n=5) and domestic dogs (n=9), which were regularly observed to feed on oryx carcasses, were collected and taeniid eggs isolated. Parasite species identification of the cysts and eggs was done by amplifying and sequencing the mitochondrial nad1 gene. Both oryx antelopes were found infected with E. ortleppi and one co-infected with E. canadensis G6/7. Both Echinococcus species were able to develop fertile cysts in oryx, making oryx antelopes competent hosts for these parasites. Therefore, the analysis of faecal samples was of high interest and although the numbers were quite small, taeniid eggs were found in three out of five faecal samples of jackals and in all nine dog samples. However, species determination was only successful with two jackal and one dog sample. All three were positive for E. canadensis G6/7. The absence of E. ortleppi may be due to the low number of faecal samples examined. In our small study, we discovered a rather unique lifecycle of Echinococcus spp. between jackals and domestic dogs as definitive hosts and oryx antelopes as intermediate hosts. Here, the presence of E. canadensis G6/7 is of particular concern, as it is the second most important causative agent of CE in humans.
Collapse
Affiliation(s)
- O. Aschenborn
- School of Veterinary Medicine, University of Namibia, Neudamm Campus, Windhoek, Namibia
- University of Hohenheim, Department of Parasitology, Emil-Wolff-Str. 34, 70599Stuttgart, Germany
- Leibniz Institute for Zoo and Wildlife Research, Department of Evolutionary Ecology, Alfred-Kowalke-Str. 17, 10315Berlin, Germany
- Ministry of Environment, Forestry and Tourism, Directorate of Scientific Services, Private Bag13306, Windhoek, Namibia
| | - J. Aschenborn
- University of Zurich, Institute of Parasitology, Winterthurerstr. 266a, 8057Zurich, Switzerland
| | - P. Kern
- University Hospital Ulm, Department of Medicine III, Albert-Einstein-Allee 23, 89081Ulm, Germany
| | - U. Mackenstedt
- University of Hohenheim, Department of Parasitology, Emil-Wolff-Str. 34, 70599Stuttgart, Germany
| | - T. Romig
- University of Hohenheim, Department of Parasitology, Emil-Wolff-Str. 34, 70599Stuttgart, Germany
| | - M. Wassermann
- University of Hohenheim, Department of Parasitology, Emil-Wolff-Str. 34, 70599Stuttgart, Germany
| |
Collapse
|
2
|
Pugh G, Fouladvand S, SantaCruz-Calvo S, Agrawal M, Zhang XD, Chen J, Kern P, Nikolajczyk B. T cells dominate peripheral inflammation in obesity-associated diabetes. The Journal of Immunology 2022. [DOI: 10.4049/jimmunol.208.supp.108.11] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
Abstract
Abstract
Many studies have examined obese/insulin-resistant mice to conclude that macrophages dominate pathogenic inflammation in metabolic disease, but few studies have ranked chronic sources of peripheral inflammation in obese people across a natural spectrum of metabolic health. We compared the relative contributions of myeloid and T cells to peripheral inflammation in samples from metabolically healthy and unhealthy obese people to address disappointing outcomes from clinical trials of anti-inflammatories in obesity-associated type 2 diabetes (T2D). We stimulated PBMCs from obese subjects with euglycemia, prediabetes, or T2D with T cell-targeting CD3/CD28 or myeloid-targeting LPS, and measured supernatant cytokines over time. Cytokines increased with time following CD3/CD28, but LPS responses were time-independent. A series of surface marker and intracellular staining assays taking into account these temporal differences in cytokine production unexpectedly showed that T cells contribute more TNFα to peripheral inflammation than do myeloid cells from all subject groups. Bioinformatic modeling combining cytokine outcomes from all subjects, stimuli, and time points, indicated IFNγ generated by CD3/CD28 stimulation was most important for differentiating peripheral inflammation in T2D compared to non-T2D samples. This result was consistent with the previously identified Th1/Th17 profile in T2D. We conclude that human T cells dominate peripheral inflammation in obesity-associated T2D, and thus targeting T cells may be an effective approach for prevention/management of obesity-associated metabolic diseases.
Supported by NIH Training Grants T32 DK007778 and TL1 UL1TR001998, R01DK108056, the Shared Resource Facility of the University of Kentucky Markey Cancer Center P30 CA177558, University of Kentucky College of Medicine, Barnstable Brown Diabetes and Obesity Center, The Center for Clinical and Translational Research (UL1TR000117), and NIH National Center for Advancing Translational Sciences UL1TR001998.
Collapse
Affiliation(s)
- Gabriella Pugh
- 1Microbiology, Immunology, & Molecular Genetics, University of Kentucky
| | | | | | - Madhur Agrawal
- 3Pharmacology & Nutritional Sciences, University of Kentucky
| | | | - Jin Chen
- 4Biostatistics, University of Kentucky
| | | | | |
Collapse
|
3
|
Gude P, Kaci CSB, Sieker M, Vogelsang H, Bellgardt M, Herzog-Niescery J, Weber TP, Weber J, Teubner S, Kern P. The influence of labor epidural analgesia on maternal, uteroplacental and fetoplacental hemodynamics in normotensive parturients: a prospective observational study. Int J Obstet Anesth 2020; 45:83-89. [PMID: 33298344 DOI: 10.1016/j.ijoa.2020.10.011] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/17/2020] [Revised: 10/05/2020] [Accepted: 10/24/2020] [Indexed: 11/27/2022]
Abstract
BACKGROUND Epidural analgesia provides sufficient analgesia during labor but can cause hypotension despite various prophylactic measures. We studied its effects on pre-placental, fetoplacental, and fetal hemodynamics using Doppler ultrasound. The primary endpoint was the pulsatility index of the umbilical artery at 30 min after establishing epidural analgesia. Secondary endpoints included maternal blood pressures and neonatal outcome data. METHODS We included healthy parturients at a cervical dilation ≥2 cm, with or without a request for epidural analgesia (n=32 per group). Ultrasound studies of the uterine arteries, umbilical artery and fetal middle cerebral artery were performed before insertion of the epidural catheter, and 30, 60 and 90 min after; the same time-points were assessed in the non-epidural control group. Maternal blood pressure was measured by a continuous non-invasive arterial pressure monitor. RESULTS Ultrasound studies detected no significant differences in pulsatility indices over time in any blood vessel. In contrast to the control group, maternal blood pressures were significantly lower for all measures after the onset of analgesia compared with baseline values (mean systolic pressure decreased from 132.7 ± 15.9 mmHg to 123.1 ± 14.4 mmHg at 30 min, P=0.003). The mean pH value of the umbilical arterial blood was 7.29 (±0.06) in the epidural group versus 7.31 (±0.08) in the control group (P=0.33). The median Apgar score at 5 min was 10 in both groups. CONCLUSIONS Pre-placental, fetoplacental and fetal hemodynamics remained stable despite a statistically significant decrease in maternal blood pressure in laboring parturients receiving epidural analgesia.
Collapse
Affiliation(s)
- P Gude
- Department of Anaesthesiology and Intensive Care Medicine, Ruhr-University Bochum, Katholisches Klinikum Bochum, Bochum, Germany.
| | - C S B Kaci
- Department of Obstetrics and Gynaecology, Ruhr-University Bochum, Katholisches Klinikum Bochum, Bochum, Germany
| | - M Sieker
- Department of Anaesthesiology and Intensive Care Medicine, Ruhr-University Bochum, Katholisches Klinikum Bochum, Bochum, Germany
| | - H Vogelsang
- Department of Anaesthesiology and Intensive Care Medicine, Ruhr-University Bochum, Katholisches Klinikum Bochum, Bochum, Germany
| | - M Bellgardt
- Department of Anaesthesiology and Intensive Care Medicine, Ruhr-University Bochum, Katholisches Klinikum Bochum, Bochum, Germany
| | - J Herzog-Niescery
- Department of Anaesthesiology and Intensive Care Medicine, Ruhr-University Bochum, Katholisches Klinikum Bochum, Bochum, Germany
| | - T P Weber
- Department of Anaesthesiology and Intensive Care Medicine, Ruhr-University Bochum, Katholisches Klinikum Bochum, Bochum, Germany
| | - J Weber
- Department of Obstetrics and Gynaecology, Ruhr-University Bochum, Katholisches Klinikum Bochum, Bochum, Germany
| | - S Teubner
- Department of Obstetrics and Gynaecology, Ruhr-University Bochum, Katholisches Klinikum Bochum, Bochum, Germany
| | - P Kern
- Department of Obstetrics and Gynaecology, Ruhr-University Bochum, Katholisches Klinikum Bochum, Bochum, Germany
| |
Collapse
|
4
|
Kern P. Der Weg in die rheumatologische Fachassistenz – ein Blick in die Historie. Z Rheumatol 2020; 79:43-44. [DOI: 10.1007/s00393-020-00860-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
5
|
Bennett S, Uy EM, Raj R, Kern P. SUN-327 Hypercalcemia and Hypoglycemia Due To EBV-Associated Lymphoma. J Endocr Soc 2019. [PMCID: PMC6553363 DOI: 10.1210/js.2019-sun-327] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
Abstract
Background: Hypercalcemia is uncommon in HIV infection but can occur in the setting of lymphoma. We describe a patient with HIV with hypercalcemia and hypoglycemia due to an initially undetected EBV-associated lymphoma. Clinical Case: A 32-year old Caucasian male with recent diagnosis of HIV was admitted for HIV arthropathy and sepsis, and found to have hypercalcemia (Ca 10.7mg/dL, n 8.9-10.2mg/dL; ionized Ca 6.1mg/dL, n 4.6-5.7mg/dL). PTH was suppressed (<10pg/mL, n 12-72pg/mL). PTH-independent causes of hypercalcemia were unremarkable for humoral hypercalcemia of malignancy (PTHrP 0.2pmol/L, n <2.0pmol/L), vitamin D toxicity (24-hydroxyvitamin D 41ng/mL, n 30-80ng/mL), granulomatous disorders (1,25-dihydroxyvitamin D 24.8pg/mL, n 19.9-79.3pg/mL; quantiferon negative), hyperthyroidism, and adrenal insufficiency. Renal function was normal and there was no thiazide, lithium, calcium, or vitamin A use. Serum protein electrophoresis (PEP) showed hypogammaglobinemia consistent with immunodeficiency. Urine PEP was negative for immunoglobulin light chains. Hypercalcemia was initially attributed to HIV with immobilization and calcium level was expected to normalize with antiretroviral therapy. Workup for infectious etiology was negative, his arthralgia and overall clinical status improved, and he was discharged. Three days later, he was readmitted for altered mental status and anemia. He was hypoglycemic, which was new on readmission, and required dextrose-containing IV fluids in addition to tube feeds to keep his serum glucose within normal range. Work up was negative for insulinoma (C peptide 0.48ng/mL, n 0.81-5.3ng/mL; glucose 31mg/dL) but IGF-2 to IGF-1 ratio was elevated at 4.57 which was suggestive of IGF-2-mediated tumor-associated hypoglycemia. Persistent leukocytosis and type B lactic acidosis also suggested an underlying malignancy. Bronchoscopy, bone marrow biopsy, and CSF cytology were negative for malignancy. CSF was positive for EBV (77,100 copies/mL). CT imaging showed liver lesions and biopsy led to the diagnosis of high-grade B-cell lymphoma. He was started on chemotherapy. Hypoglycemia resolved 10 days later, as did the lactic acidosis. Hypercalcemia was treated with pamidronate with return to normal levels. Conclusion: Hypercalcemia in an HIV patient warrants diligent workup. Hypercalcemia in lymphomas are often attributed to elevated 1,25-dihydroxyvitamin D. A possible explanation for normal 1,25-dihydroxyvitamin D observed in our patient is the effect of antiretroviral therapy on accelerated catabolism of vitamin D. Hypoglycemia may be due to IGF-2 production by tumor and malignancy-related glucose consumption via glycolytic pathway with lactic acid production. Literature on concurrent hypercalcemia and hypoglycemia with B-cell lymphoma is sparse and, to our knowledge, occurrence in the setting of HIV has not been reported.
Collapse
Affiliation(s)
- Sonia Bennett
- University of Kentucky, Lexington, KY, United States
| | | | - Rishi Raj
- University of Kentucky, Lexington, KY, United States
| | - Philip Kern
- UK Healthcare - Endocrinology, University of Kentucky School of Medicine, Lexington, KY, United States
| |
Collapse
|
6
|
Kern P, Finlin B, Confides A, Zhu B, Memetimin H, Johnson Z, Westgate P, Dupont-Versteegden E. OR01-4 Mast Cells and Human Adipose Beiging: Mast Cells Are Recruited to Subcutaneous White Adipose and Degranulate in Response to Cold. J Endocr Soc 2019. [PMCID: PMC6554760 DOI: 10.1210/js.2019-or01-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
Abstract
Beige adipose tissue is induced in humans in response to cold, due in part to sympathetic nervous system (SNS) activation. We have previously found that mast cells promote seasonal induction of beige adipose tissue in humans and that in vitro mast cells sensed the cold and released histamine, promoting adipocyte beiging through activation of PKA (1). In recent studies, subcutaneous white adipose tissue (SC WAT) beiging was induced in lean and obese participants in response to repeated cold application (30 min ice pack for 10 days) in the summer (2). Interestingly, UCP1 and TMEM26, which are beige adipose markers, were induced in the cold-treated and non-treated, contralateral leg (2). We performed multiplex analysis of gene expression with the Nanostring nCounter system (with a probe set containing genes for specific immune cell markers, cytokines, and chemokines) on the SC WAT from this cohort of lean subjects to identify factors that promote or inhibit beiging. Multivariate analysis identified mast cell tryptase (r=0.77; P=0.003; n=12) and CCL26, a chemokine for mast cells, (r=0.71; P=0.009; n=12) as genes whose change correlated positively with the change in UCP1 in SC WAT of the cold treated leg, suggesting that mast cells are involved in SC WAT beiging. Immunohistochemistry was used to quantitate mast cell recruitment and degranulation into SC WAT. Mast cells increased in number in SC WAT of both the cold treated and contralateral legs in lean (1.6-fold increase (P<0.01)), but not obese subjects. However, there was an increase in the number of degranulated mast cells in SC WAT of the cold treated (P<0.0001) and contralateral (P<0.01) legs of both lean and obese subjects, suggesting that SNS-induced norepinephrine (NE) stimulated mast cell degranulation. To examine this in vitro, norepinephrine was added to cultured mast cells and histamine release was measured; NE potently stimulated histamine release (P<0.0001). In conclusion, cold stimulated mast cell recruitment and degranulation in SC WAT of lean and obese research participants, suggesting that mast cells promote adipose beiging through the release of histamine or other products. References: 1. Finlin BS, Zhu B, Confides AL, Westgate PM, Harfmann BD, Dupont-Versteegden EE, et al. Mast Cells Promote Seasonal White Adipose Beiging in Humans. Diabetes. 2017;66(5):1237-46. 2. Finlin BS, Memetimin H, Confides AL, Kasza I, Zhu B, Vekaria HJ, et al. Human adipose beiging in response to cold and mirabegron. JCI Insight. 2018;3(15).
Collapse
Affiliation(s)
- Philip Kern
- University of Kentucky School of Medicine, Lexington, KY, United States
| | - Brian Finlin
- University of Kentucky School of Medicine, Lexington, KY, United States
| | - Amy Confides
- University of Kentucky School of Medicine, Lexington, KY, United States
| | - Beibei Zhu
- University of Kentucky School of Medicine, Lexington, KY, United States
| | - Hasiyet Memetimin
- University of Kentucky School of Medicine, Lexington, KY, United States
| | - Zachary Johnson
- University of Kentucky School of Medicine, Lexington, KY, United States
| | | | | |
Collapse
|
7
|
Hemmer CJ, Bierhaus A, Riedesel JV, Gabat S, Liliensiek B, Pitronik P, Lin J, Grauer A, Amiral J, Ziegler R, Schieffer S, Kern P, Seitz R, Egbring R, Dietrich M, Nawroth PP. Elevated Thrombomodulin Plasma Levels as a Result of Endothelial Involvement in Plasmodium falciparum Malaria. Thromb Haemost 2018. [DOI: 10.1055/s-0038-1648889] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Abstract
SummaryWe used thrombomodulin (TM) to assess the participation of the vascular endothelium in human Plasmodium falciparum (P. F.) malaria. Before therapy TM plasma levels were elevated in P. F. malaria and fell to normal values during therapy. Parasitemia, TNFα, elastase and TAT levels correlated directly with TM. Elevated TM levels can not be explained by increased synthesis, since incubating HUVEC with pretherapy serum of patients with P. F. malaria, but not reconvalescence serum, suppressed TM transcription. This was partially prevented by adding a TNFα neutralizing antibody to patient serum before incubation with HUVEC. However, TNFα does not release TM from cultured HUVEC in vitro. Coincubation of HUVEC with pretherapy serum together with neutrophils resulted in endothelial cell destruction, which could be partly prevented by a TNFα neutralizing antibody. Hence the increase of TM during P. F. malaria might reflect the concerted action of cytokines and neutrophils on HUVEC.
Collapse
Affiliation(s)
- Christoph J Hemmer
- The Department of Medicine, Bernhard-Nocht-lnstitute for Tropical Medicine, Hamburg, Germany
| | - A Bierhaus
- Department of Medicine, University of Heidelberg, Germany
| | - J v Riedesel
- Department of Medicine, University of Heidelberg, Germany
| | - S Gabat
- Department of Medicine, University of Heidelberg, Germany
| | - B Liliensiek
- Department of Medicine, University of Heidelberg, Germany
| | - P Pitronik
- Department of Medicine, University of Heidelberg, Germany
| | - J Lin
- Department of Medicine, University of Heidelberg, Germany
| | - A Grauer
- Department of Medicine, University of Heidelberg, Germany
| | - J Amiral
- SERBIO Research Laboratories, Gennevilliers, France
| | - R Ziegler
- Department of Medicine, University of Heidelberg, Germany
| | - S Schieffer
- Infectious Diseases and Clinical Immunology Section, University of Ulm
| | - P Kern
- Infectious Diseases and Clinical Immunology Section, University of Ulm
| | - R Seitz
- Department of Hematology, Hemostaseology Section, University of Marburg, Germany
| | - R Egbring
- Department of Hematology, Hemostaseology Section, University of Marburg, Germany
| | - M Dietrich
- The Department of Medicine, Bernhard-Nocht-lnstitute for Tropical Medicine, Hamburg, Germany
| | - P P Nawroth
- Department of Medicine, University of Heidelberg, Germany
| |
Collapse
|
8
|
Abstract
Objective Telangiectasias of the lower legs are intradermal dilatations of the subpapillary venous plexus, but their pathophysiology and risk factors are still largely unknown. The purpose of this review is to summarize the current knowledge on the pathophysiology and risk factors for telangiectasias. Methods A systematic review of the literature indexed in Medline completed with textbooks and European phlebology journals from the French, Swiss, and German phlebology societies was performed. Results A multitude of risk factors and several pathophysiological hypotheses, such as reflux, arterio-venous micro-shunts, parietal, and connective tissue abnormalities, are described in the literature. The different hypotheses are discussed and put in a clinical perspective, in particular their therapeutic implications for phlebologists. Conclusion In conclusion, pathophysiology and risk factors of telangiectasias are still largely unknown, and a better understanding could improve treatment results and reduce recurrence.
Collapse
Affiliation(s)
- P Kern
- 1 Private Practice in Vascular Medicine, Vevey, Switzerland
- 2 Service of Angiology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland
| |
Collapse
|
9
|
Kern P, Kimmig R, Rezai M, Hoffmann O, Bücker I, Braun M. Abstract OT2-01-05: Sentinel lymphnode biopsy (SLNB) and targeted axillary surgery (TAS) by indocyaningreen (ICG) and a novel near-infrared color camera system - a prospectively randomised, multicenter study to avoid radioactivity in a time-/cost-saving procedure in primary breast cancer. Cancer Res 2018. [DOI: 10.1158/1538-7445.sabcs17-ot2-01-05] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Sentinel lymph node biopsy (SLNB) by radioactively labelled 99mTechnetium +/- patent blue is so far the current standard in SLN detection. However, it remains a time- and cost-consuming procedure requiring the availability of a nuclear medicine department and a precise coordination with the subsequent surgery. It could be desirable to empower surgeons to be independent from availability of a nuclear source and to spare patients from radioactivity. Indocyanine green (ICG) as a fluorescent coloring agent is already known as safe in diagnostics for heart, circulation, liver and eye disease and may represent a valid alternative to 99mTc and patent blue (PBD), especially as it does not cause aesthetic impairment of the breast, with ICG being only visible with near infra-red light.
Methods: This prospective, randomized study is a non-inferiority trial to evaluate ICG-fluorescence as an alternative to either 99mTc and/or patent blue dye for sentinel lymph node detection of primary breast cancer with and without neoadjuvant chemotherapy.
Patients, aged 18 - 80 years, with unilateral or bilateral, unifocal or multifocal/ multicentric primary breast cancer without signs of metastases and written consent are eligible for this study. ECOG status of 0-2 and life expectancy > 1 year is required. All BMI classes are admitted to the study, with predefined subgroups of a) <= 20 b) >20-30 c) >30-40 d) >40. Tumor stages included are a) Tis (>= 4 cm) b) T1 c) T2 and d) T3. ICG-guided SLNB may be applied in patients in the following settings: a) before neoadjuvant, b) after neoadjuvant chemotherapy.
Primary Endpoints: Rate of SLN detection by either of the methods in the following 3 arms of the trial:
Arm A: 99mTc + patent blue dye (PBD)
Arm B: 99mTc + indocyanine green (ICG)
Arm C: Indocyanine green (ICG)
Secondary Endpoints:
- Time to identify (TTI) sentinel lymph node(s) (min)
- Number of sentinel lymph nodes (SLN) and non-sentinel lymph nodes (non-SLN)
- Rate of concordance of detection by 99mTc+patent blue dye (PBD) vs. 99mTc + ICG
- Dose of radioactivity omitted in Arm C vs. Arm A & B
Results: This trial is in progress.
Citation Format: Kern P, Kimmig R, Rezai M, Hoffmann O, Bücker I, Braun M. Sentinel lymphnode biopsy (SLNB) and targeted axillary surgery (TAS) by indocyaningreen (ICG) and a novel near-infrared color camera system - a prospectively randomised, multicenter study to avoid radioactivity in a time-/cost-saving procedure in primary breast cancer [abstract]. In: Proceedings of the 2017 San Antonio Breast Cancer Symposium; 2017 Dec 5-9; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2018;78(4 Suppl):Abstract nr OT2-01-05.
Collapse
Affiliation(s)
- P Kern
- University of Bochum, Teaching Hospital St.Elisabeth´s Hospital, Bochum, Northrhine-Westfalia, Germany; University of Duisburg-Essen, University Hospital of Essen, Essen, Northrhine-Westfalia, Germany; Breast Center Düsseldorf Luisenkrankenhaus, Düsseldorf, Northrhine-Westfalia, Germany; Rotkreuzklinikum München, München, Bavaria, Germany
| | - R Kimmig
- University of Bochum, Teaching Hospital St.Elisabeth´s Hospital, Bochum, Northrhine-Westfalia, Germany; University of Duisburg-Essen, University Hospital of Essen, Essen, Northrhine-Westfalia, Germany; Breast Center Düsseldorf Luisenkrankenhaus, Düsseldorf, Northrhine-Westfalia, Germany; Rotkreuzklinikum München, München, Bavaria, Germany
| | - M Rezai
- University of Bochum, Teaching Hospital St.Elisabeth´s Hospital, Bochum, Northrhine-Westfalia, Germany; University of Duisburg-Essen, University Hospital of Essen, Essen, Northrhine-Westfalia, Germany; Breast Center Düsseldorf Luisenkrankenhaus, Düsseldorf, Northrhine-Westfalia, Germany; Rotkreuzklinikum München, München, Bavaria, Germany
| | - O Hoffmann
- University of Bochum, Teaching Hospital St.Elisabeth´s Hospital, Bochum, Northrhine-Westfalia, Germany; University of Duisburg-Essen, University Hospital of Essen, Essen, Northrhine-Westfalia, Germany; Breast Center Düsseldorf Luisenkrankenhaus, Düsseldorf, Northrhine-Westfalia, Germany; Rotkreuzklinikum München, München, Bavaria, Germany
| | - I Bücker
- University of Bochum, Teaching Hospital St.Elisabeth´s Hospital, Bochum, Northrhine-Westfalia, Germany; University of Duisburg-Essen, University Hospital of Essen, Essen, Northrhine-Westfalia, Germany; Breast Center Düsseldorf Luisenkrankenhaus, Düsseldorf, Northrhine-Westfalia, Germany; Rotkreuzklinikum München, München, Bavaria, Germany
| | - M Braun
- University of Bochum, Teaching Hospital St.Elisabeth´s Hospital, Bochum, Northrhine-Westfalia, Germany; University of Duisburg-Essen, University Hospital of Essen, Essen, Northrhine-Westfalia, Germany; Breast Center Düsseldorf Luisenkrankenhaus, Düsseldorf, Northrhine-Westfalia, Germany; Rotkreuzklinikum München, München, Bavaria, Germany
| |
Collapse
|
10
|
Solomon N, Zeyhle E, Subramanian K, Fields PJ, Romig T, Kern P, Carter JY, Wachira J, Mengiste A, Macpherson CNL. Cystic echinococcosis in Turkana, Kenya: 30 years of imaging in an endemic region. Acta Trop 2018; 178:182-189. [PMID: 29155205 DOI: 10.1016/j.actatropica.2017.11.006] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2017] [Revised: 11/06/2017] [Accepted: 11/15/2017] [Indexed: 12/28/2022]
Abstract
Cystic echinococcosis (CE), a widespread, complex zoonosis, causes chronic disease associated with high morbidity. The pastoral Turkana people of Kenya have one of the highest prevalence rates of CE in the world. Between 1983 and 2015, a CE control program in the Turkana region used ultrasound (US) screening surveys and surgical outreach visits to evaluate CE prevalence and treat those with the disease. As the gold standard modality for diagnosing CE, US reveals a great deal of information about the disease in affected populations. The aim of this study is to discuss the characteristics of untreated CE in the Turkana people as revealed by US data collected during the CE control program and evaluate disease presentation, factors influencing the risk of transmission, and the timeline of disease progression. Data were obtained from written patient notes from US screenings and images; cysts were classified using the World Health Organization (WHO) standardized US classification of CE. Findings include greater prevalence of cysts, later stages of cysts, and multiple cysts in older age groups, with no multiple cysts occurring in patients under six years of age, which are consistent with the assertion that rates of exposure, transmission, and infection increase with age in endemic regions. Findings also raise questions regarding the timeline of disease progression, and factors potentially influencing disease transmission within this and other endemic populations. A comprehensive survey focusing on cultural and community observations (e.g., changing behaviors, hygienic practices, etc.) may provide more detailed information regarding factors that facilitate transmission.
Collapse
Affiliation(s)
- N Solomon
- Windward Islands Research and Education Foundation (WINDREF), P.O. Box 7, St. George's, Grenada; St. George's University School of Medicine, P.O. Box 7, St. George's, Grenada.
| | - E Zeyhle
- Meru University of Science and Technology, Mararo Road, Carlton Court, C1, Nairobi, Kenya.
| | - K Subramanian
- St. George's University School of Medicine, P.O. Box 7, St. George's, Grenada.
| | - P J Fields
- Windward Islands Research and Education Foundation (WINDREF), P.O. Box 7, St. George's, Grenada; St. George's University School of Medicine, P.O. Box 7, St. George's, Grenada; St. George's University School of Veterinary Medicine, P.O. Box 7, St. George's, Grenada.
| | - T Romig
- University of Hohenheim, FG Parasitologie 220B, Emil-Wolff-Str. 31, 70599, Stuttgart, Germany.
| | - P Kern
- University of Ulm, Division of Infectious Diseases and Clinical Immunology, Department of Medicine III, Albert-Einstein-Allee 23, 89081 Ulm, Germany.
| | - J Y Carter
- Outreach Program, Amref Health Africa, PO Box 30125, 00100 GPO, Nairobi, Kenya.
| | - J Wachira
- Outreach Program, Amref Health Africa, PO Box 30125, 00100 GPO, Nairobi, Kenya.
| | - A Mengiste
- Outreach Program, Amref Health Africa, PO Box 30125, 00100 GPO, Nairobi, Kenya.
| | - C N L Macpherson
- Windward Islands Research and Education Foundation (WINDREF), P.O. Box 7, St. George's, Grenada; St. George's University School of Medicine, P.O. Box 7, St. George's, Grenada; St. George's University School of Veterinary Medicine, P.O. Box 7, St. George's, Grenada.
| |
Collapse
|
11
|
Kern P, Cramp RL, Gordos MA, Watson JR, Franklin CE. Measuring U crit and endurance: equipment choice influences estimates of fish swimming performance. J Fish Biol 2018; 92:237-247. [PMID: 29193071 DOI: 10.1111/jfb.13514] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/26/2017] [Accepted: 11/07/2017] [Indexed: 06/07/2023]
Abstract
This study compared the critical swimming speed (Ucrit ) and endurance performance of three Australian freshwater fish species in different swim-test apparatus. Estimates of Ucrit measured in a large recirculating flume were greater for all species compared with estimates from a smaller model of the same recirculating flume. Large differences were also observed for estimates of endurance swimming performance between these recirculating flumes and a free-surface swim tunnel. Differences in estimates of performance may be attributable to variation in flow conditions within different types of swim chambers. Variation in estimates of swimming performance between different types of flumes complicates the application of laboratory-based measures to the design of fish passage infrastructure.
Collapse
Affiliation(s)
- P Kern
- School of Biological Sciences, The University of Queensland, Brisbane, 4072, Australia
| | - R L Cramp
- School of Biological Sciences, The University of Queensland, Brisbane, 4072, Australia
| | - M A Gordos
- Department of Primary Industries Fisheries, Wollongbar, New South Wales, 2477, Australia
| | - J R Watson
- School of Biological Sciences, The University of Queensland, Brisbane, 4072, Australia
| | - C E Franklin
- School of Biological Sciences, The University of Queensland, Brisbane, 4072, Australia
| |
Collapse
|
12
|
van Dam P, Tomatis M, Marotti L, Heil J, Mansel R, Rosselli del Turco M, van Dam P, Casella D, Bassani L, Danei M, Denk A, Egle D, Emons G, Friedrichs K, Harbeck N, Kiechle M, Kimmig R, Koehler U, Kuemmel S, Maass N, Mayr C, Prové A, Rageth C, Regolo L, Lorenz-Salehi F, Sarlos D, Singer C, Sohn C, Staelens G, Tinterri C, Audisio R, Ponti A, Badbanchi F, Catalano G, Cretella E, Daniaux M, Emons A, van Eygen K, Ettl J, Gatzemeier W, Kern P, Schneeweiss A, Stoeblen F, Van As A, Wuerstlein R, Zanini V. Time trends (2006–2015) of quality indicators in EUSOMA-certified breast centres. Eur J Cancer 2017; 85:15-22. [DOI: 10.1016/j.ejca.2017.07.040] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2016] [Revised: 05/31/2017] [Accepted: 07/25/2017] [Indexed: 12/21/2022]
|
13
|
Blind N, Le Coarer E, Kern P, Gousset S. Spectrographs for astrophotonics. Opt Express 2017; 25:27341-27369. [PMID: 29092210 DOI: 10.1364/oe.25.027341] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/08/2017] [Accepted: 06/28/2017] [Indexed: 05/27/2023]
Abstract
The next generation of extremely large telescopes (ELT), with diameters up to 39 meters, is planned to begin operation in the next decade and promises new challenges in the development of instruments since the instrument size increases in proportion to the telescope diameter D, and the cost as D2 or faster. The growing field of astrophotonics (the use of photonic technologies in astronomy) could solve this problem by allowing mass production of fully integrated and robust instruments combining various optical functions, with the potential to reduce the size, complexity and cost of instruments. Astrophotonics allows for a broad range of new optical functions, with applications ranging from sky background filtering, high spatial and spectral resolution imaging and spectroscopy. In this paper, we want to provide astronomers with valuable keys to understand how photonics solutions can be implemented (or not) according to the foreseen applications. The paper introduces first key concepts linked to the characteristics of photonics technologies, placed in the framework of astronomy and spectroscopy. We then describe a series of merit criteria that help us determine the potential of a given micro-spectrograph technology for astronomy applications, and then take an inventory of the recent developments in integrated micro-spectrographs with potential for astronomy. We finally compare their performance, to finally draw a map of typical science requirements and pin the identified integrated technologies on it. We finally emphasize the necessary developments that must support micro-spectrograph in the coming years.
Collapse
|
14
|
Kern P, Menezes da Silva A, Akhan O, Müllhaupt B, Vizcaychipi KA, Budke C, Vuitton DA. The Echinococcoses: Diagnosis, Clinical Management and Burden of Disease. Adv Parasitol 2017; 96:259-369. [PMID: 28212790 DOI: 10.1016/bs.apar.2016.09.006] [Citation(s) in RCA: 255] [Impact Index Per Article: 36.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
The echinococcoses are chronic, parasitic diseases that are acquired after ingestion of infective taeniid tapeworm eggs from certain species of the genus Echinococcus. Cystic echinococcosis (CE) occurs worldwide, whereas, alveolar echinococcosis (AE) is restricted to the northern hemisphere, and neotropical echinococcosis (NE) has only been identified in Central and South America. Clinical manifestations and disease courses vary profoundly for the different species of Echinococcus. CE presents as small to large cysts, and has commonly been referred to as 'hydatid disease', or 'hydatidosis'. A structured stage-specific approach to CE management, based on the World Health Organization (WHO) ultrasound classification of liver cysts, is now recommended. Management options include percutaneous sterilization techniques, surgery, drug treatment, a 'watch-and-wait' approach or combinations thereof. In contrast, clinical manifestations associated with AE resemble those of a 'malignant', silently-progressing liver disease, with local tissue infiltration and metastases. Structured care is important for AE management and includes WHO staging, drug therapy and long-term follow-up for at least a decade. NE presents as polycystic or unicystic disease. Clinical characteristics resemble those of AE, and management needs to be structured accordingly. However, to date, only a few hundreds of cases have been reported in the literature. The echinococcoses are often expensive and complicated to treat, and prospective clinical studies are needed to better inform case management decisions.
Collapse
Affiliation(s)
- P Kern
- University Hospital of Ulm, Ulm, Germany
| | | | - O Akhan
- Hacettepe University, Ankara, Turkey
| | - B Müllhaupt
- University Hospital of Zurich, Zürich, Switzerland
| | - K A Vizcaychipi
- National Institute of Infectious Diseases, Buenos Aires, Argentina
| | - C Budke
- Texas A&M University, College Station, TX, United States
| | - D A Vuitton
- Université de Franche-Comté, Besançon, France
| |
Collapse
|
15
|
Bhatti T, Kern P. An integral representation of dilatively stable processes with independent increments. Stoch Process Their Appl 2017. [DOI: 10.1016/j.spa.2016.06.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
16
|
Kern P, Bücker I, Kimmig R, Braun M. Genomic Testing im Real-Life-Szenario – Einfluss neuer genomischer Test außerhalb klinischer Studien. Geburtshilfe Frauenheilkd 2016. [DOI: 10.1055/s-0036-1593136] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
17
|
Affiliation(s)
- P. Kern
- Universitätsmedizin Marburg – Campus Fulda, Medizinische Klinik IV Klinikum Fulda, Fulda, Deutschland
| |
Collapse
|
18
|
Mayer-Pickel K, Stroedter L, Kern P, Pilhatsch A, Tamussino K. Isolierte distale Vaginalatresie: Bildgebung und operative Korrektur. Geburtshilfe Frauenheilkd 2016. [DOI: 10.1055/s-0036-1582179] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
19
|
Kern P. A General Multiparameter Version of Gnedenko's Transfer Theorem. Theory Probab Appl 2016. [DOI: 10.1137/s0040585x97t987569] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
20
|
van Dam P, Tomatis M, Marotti L, Heil J, Wilson R, Rosselli del Turco M, Mayr C, Costa A, Danei M, Denk A, Emons G, Friedrichs K, Harbeck N, Kiechle M, Koheler U, Kuemmel S, Maass N, Marth C, Prové A, Kimmig R, Rageth C, Regolo L, Salehi L, Sarlos D, Singer C, Sohn C, Staelens G, Tinterri C, Ponti A, Cretella E, Kern P, Stoeblen F, Emons A, van Eygen K, Ettl J, Zanini V, Van As A, Daniaux M, Gatzemeier W, Catalano G, Schneeweiss A, Wuerstlein R. The effect of EUSOMA certification on quality of breast cancer care. Eur J Surg Oncol 2015; 41:1423-9. [DOI: 10.1016/j.ejso.2015.06.006] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2015] [Revised: 06/04/2015] [Accepted: 06/12/2015] [Indexed: 12/12/2022] Open
|
21
|
Kern P, Faiss J. P50. An extraordinary hour glass forming enhancing mass in the neuroforamina L2/3 with spontaneously complete remission. Clin Neurophysiol 2015. [DOI: 10.1016/j.clinph.2015.04.186] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
22
|
Kern P, Zarth F, Kimmig R, Rezai M. Impact of Age, Obesity and Smoking on Patient Satisfaction with Breast Implant Surgery - A Unicentric Analysis of 318 Implant Reconstructions after Mastectomy. Geburtshilfe Frauenheilkd 2015; 75:597-604. [PMID: 26166841 DOI: 10.1055/s-0035-1546171] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2015] [Revised: 05/05/2015] [Accepted: 05/07/2015] [Indexed: 12/11/2022] Open
Abstract
Aim: Breast reconstruction has become increasingly important for the body image of women with breast cancer. We conducted a study to investigate how patient characteristics correlate with surgical outcome after breast reconstruction with implant after mastectomy and to identify risk factors which could facilitate patient selection for reconstruction. Patients and Methods: For this case cohort analysis (n = 257 patients with 318 heterologous reconstructions), we analyzed BMI, smoking, pre-existing disease, chemotherapy and radiotherapy, one-stage/two-stage reconstruction, immediate/delayed reconstruction, antibiotic therapy and complications, partner interaction and adherence to the decision for reconstruction using a customized questionnaire. Results: 257 patients with 318 implant reconstructions (196 unilateral, 61 bilateral) were eligible for inclusion in the study. Median follow-up time was 3.1 years (range: 1 month to 10 years). Response rate to the questionnaire was 71.8 %. Median age was 49 years (range 24-79 years), median BMI was 22.44 (range 16.33-40.09). A BMI > 30 was inversely correlated with positive self-image (p = 0.004), and implant loss/rotation was more frequent in this group (p < 0.05). Smoking > 10 cigarettes/day had a negative impact on surgical outcome. A positive self-image had a positive impact on partner interaction (p < 0.001) and was correlated with a lower perception of pain. Aesthetic results did not vary with age (p = 0.054). Titanized polypropylene meshes were used to protect against implant rotation (p = 0.034). Rates of capsular fibrosis were low in our cohort (< 10 %), and implant loss rate was less than 2 %. Conclusions: This study offers a differentiated approach for the pre-surgical counselling of patients and shows that patients up to 80 years of age are highly satisfied with implant reconstruction. A high BMI and smoking > 10 cigarettes/day are unfavorable preconditions for implant reconstruction. The use of prophylactic antibiotics was confirmed as beneficial for surgical outcome. A positive self-image after reconstruction strongly influences partner interaction.
Collapse
Affiliation(s)
- P Kern
- Department of Gynecology and Obstetrics; University Hospital Essen, Essen ; Breast Center Düsseldorf, Luisenkrankenhaus, Düsseldorf
| | - F Zarth
- Department of Gynecology and Obstetrics; University Hospital Essen, Essen
| | - R Kimmig
- Department of Gynecology and Obstetrics; University Hospital Essen, Essen
| | - M Rezai
- Breast Center Düsseldorf, Luisenkrankenhaus, Düsseldorf
| |
Collapse
|
23
|
Kern P. Immune Response to Parasitic Infections, Volume 2--Immunity to Helminths and Novel Therapeutic Approaches. Clin Infect Dis 2015. [DOI: 10.1093/cid/civ175] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
24
|
Rezai M, Kellersmann S, Knispel S, Lax H, Kimmig R, Kern P. Translating the concept of intrinsic subtypes into an oncoplastic cohort of more than 1000 patients - predictors of recurrence and survival. Breast 2015; 24:384-90. [PMID: 25987488 DOI: 10.1016/j.breast.2015.02.030] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2014] [Revised: 02/01/2015] [Accepted: 02/22/2015] [Indexed: 11/19/2022] Open
Abstract
INTRODUCTION A paradigm shift in breast cancer was introduced by Sørlie's concept of intrinsic subtypes [1]. We validated this concept - which was originally based on 84 individuals - in a large cohort study of 1035 patients with oncoplastic surgery and analyzed if early and late recurrences are linked to a specific intrinsic tumor subtype or resection margins. MATERIALS AND METHODS 1035 patients with oncoplastic surgery (2004-2009) were analyzed with regard to treatment characteristics and patterns of early (<5 years) and late recurrence (>5 years) and survival related to the intrinsic subtypes. Data was retrieved from patient's charts, customized patients questionnaires and cancer registries. RESULTS 944 patients with primary, unilateral breast cancer, median age 58 years, were eligible for analysis. At a median FU of 5.2 years, LRR was 4.0%, 5-year-OS 94.5% and DFS 90.9%. Intrinsic subtypes, but not T-size, nodal-status, resections margins nor histopathology, governed local control and survival. There was no signal for prevelance of unclear margins in any of intrinsic subgroups and no preference of any oncoplastic technique attributed to them. TNBC and Her2 non-luminal breast cancer had highest recurrence and lowest survival rates. Although sentinel involvement (SLN+) was prevailing in the Luminal-B-Her 2 negative subtype at 34.3%, this did not translate into a higher axillary dissection rate. CONCLUSION This study confirmed the intrinsic subtype concept on a large clinical basis and describes the patterns of early and late recurrence in oncoplastic surgery, concluding that bigger risk may not be overcome by bigger surgery.
Collapse
Affiliation(s)
- M Rezai
- Breast Center Düsseldorf Luisenkrankenhaus, Director: Dr.Mahdi Rezai, Hans-Günther-Sohl-Str.6-10, 40235 Düsseldorf, Germany
| | - S Kellersmann
- Breast Center Düsseldorf Luisenkrankenhaus, Director: Dr.Mahdi Rezai, Hans-Günther-Sohl-Str.6-10, 40235 Düsseldorf, Germany; University Hospital of Essen, Department of Gynecology and Obstetrics, West German Cancer Center, Hufelandstr.55, D-45147 Essen, Germany
| | - S Knispel
- Breast Center Düsseldorf Luisenkrankenhaus, Director: Dr.Mahdi Rezai, Hans-Günther-Sohl-Str.6-10, 40235 Düsseldorf, Germany; University Hospital of Essen, Department of Gynecology and Obstetrics, West German Cancer Center, Hufelandstr.55, D-45147 Essen, Germany
| | - H Lax
- Institute for Medical Informatics, Biometry and Epidemiology (IMIBE), Zweigertstr. 37, D-45130 Essen, Germany
| | - R Kimmig
- University Hospital of Essen, Department of Gynecology and Obstetrics, West German Cancer Center, Hufelandstr.55, D-45147 Essen, Germany
| | - P Kern
- Breast Center Düsseldorf Luisenkrankenhaus, Director: Dr.Mahdi Rezai, Hans-Günther-Sohl-Str.6-10, 40235 Düsseldorf, Germany; University Hospital of Essen, Department of Gynecology and Obstetrics, West German Cancer Center, Hufelandstr.55, D-45147 Essen, Germany
| |
Collapse
|
25
|
|
26
|
|
27
|
Rezai M, Kellersmann S, Knispel S, Kimmig R, Kern P. PG 9.05 Breast conservative surgery and local recurrence. Breast 2015. [DOI: 10.1016/s0960-9776(15)70038-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
28
|
Kagendo D, Magambo J, Agola E, Njenga S, Zeyhle E, Mulinge E, Gitonga P, Mbae C, Muchiri E, Wassermann M, Kern P, Romig T. A survey for Echinococcus spp. of carnivores in six wildlife conservation areas in Kenya. Parasitol Int 2014; 63:604-11. [DOI: 10.1016/j.parint.2014.04.001] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2013] [Revised: 03/31/2014] [Accepted: 04/04/2014] [Indexed: 10/25/2022]
|
29
|
Hamel-Desnos C, Desnos P, Allaert FA, Kern P. Thermal ablation of saphenous veins is feasible and safe in patients older than 75 years: A prospective study (EVTA study). Phlebology 2014; 30:525-32. [PMID: 24942061 DOI: 10.1177/0268355514540882] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
OBJECTIVES To investigate the tolerance and safety of thermal ablation (TA), consisting of radiofrequency or endovenous laser (EVLA) of saphenous veins (SV) in elderly (group 1 ≥75 years), compared with a control group (group 2 <75 years). METHOD An Observational multicenter-prospective study was conducted, under the aegis of the French and Swiss Societies of Phlebology (18 centers). Ninety patients were included in group 1, 617 in group 2 (mean age 80 years and 53 years; 69% women in both groups), representing 863 SV. Mean trunk diameters were similar in both groups (small SV: 6 mm; great SV: 7 mm). In group 1, comorbidities were more frequent, particularly cardiac insufficiency, diabetes, history of thrombosis, and CEAP clinical class was significantly higher. RESULTS EVLA was used in 86% of cases. Settings used were similar in both groups for each technique. Only 6% of TA was performed in an operating room for group 1 (14% group 2). Tumescent local anaesthesia (TLA) alone was used in 91% of cases in group 1 (85% group 2). The mean pain score was only 1.6 for the procedure itself (VASP 0-10; 10 max.) and 1.4 for the 10 days following the procedure. Side effects were few, but rate of paraesthesia was higher when general anaesthesia was used (11.8%) compared with TLA alone (2.2%). At three months, 100% of SV was occluded in group 1 (99.5% group 2), with high satisfaction score (9.3/10). CONCLUSION TA is safe and effective in elderly; it should be performed strictly under TLA to minimize side effects.
Collapse
Affiliation(s)
| | - P Desnos
- French Society of Phlebology, Paris, France
| | - F-A Allaert
- Medical Evaluation Chair and Cenbiotech, Dijon, France
| | - P Kern
- Private Office of Vascular Medicine and Service of Angiology, University Hospital Lausanne, Vevey, Switzerland
| | | |
Collapse
|
30
|
D'Amico C, Cheng G, Mauclair C, Troles J, Calvez L, Nazabal V, Caillaud C, Martin G, Arezki B, LeCoarer E, Kern P, Stoian R. Large-mode-area infrared guiding in ultrafast laser written waveguides in sulfur-based chalcogenide glasses. Opt Express 2014; 22:13091-13101. [PMID: 24921505 DOI: 10.1364/oe.22.013091] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Abstract
Current demands in astrophotonics impose advancing optical functions in infrared domains within embedded refractive index designs. We demonstrate concepts for large-mode-area guiding in ultrafast laser photowritten waveguides in bulk Sulfur-based chalcogenide glasses. If positive index contrasts are weak in As2S3, Ge doping increases the matrix rigidity and allows for high contrast (10(-3)) positive refractive index changes. Guiding with variable mode diameter and large-mode-area light transport is demonstrated up to 10 μm spectral domain using transverse slit-shaped and evanescently-coupled multicore traces.
Collapse
|
31
|
Patlewicz G, Kuseva C, Mehmed A, Popova Y, Dimitrova G, Ellis G, Hunziker R, Kern P, Low L, Ringeissen S, Roberts DW, Mekenyan O. TIMES-SS--recent refinements resulting from an industrial skin sensitisation consortium. SAR QSAR Environ Res 2014; 25:367-391. [PMID: 24785905 DOI: 10.1080/1062936x.2014.900520] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Abstract
The TImes MEtabolism Simulator platform for predicting Skin Sensitisation (TIMES-SS) is a hybrid expert system, first developed at Bourgas University using funding and data from a consortium of industry and regulators. TIMES-SS encodes structure-toxicity and structure-skin metabolism relationships through a number of transformations, some of which are underpinned by mechanistic 3D QSARs. The model estimates semi-quantitative skin sensitisation potency classes and has been developed with the aim of minimising animal testing, and also to be scientifically valid in accordance with the OECD principles for (Q)SAR validation. In 2007 an external validation exercise was undertaken to fully address these principles. In 2010, a new industry consortium was established to coordinate research efforts in three specific areas: refinement of abiotic reactions in the skin (namely autoxidation) in the skin, refinement of the manner in which chemical reactivity was captured in terms of structure-toxicity rules (inclusion of alert reliability parameters) and defining the domain based on the underlying experimental data (study of discrepancies between local lymph node assay Local Lymph Node Assay (LLNA) and Guinea Pig Maximisation Test (GPMT)). The present paper summarises the progress of these activities and explains how the insights derived have been translated into refinements, resulting in increased confidence and transparency in the robustness of the TIMES-SS predictions.
Collapse
Affiliation(s)
- G Patlewicz
- a DuPont Haskell Global Centers for Health and Environmental Sciences , Newark DE , USA
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
32
|
Just B, Kern P, Luthardt R, Rudolph H, Grüner B, Wahlers K. Echinococcus cysts affecting oromaxillofacial structures--a systematic review. Oral Dis 2014; 20:756-61. [PMID: 24495132 DOI: 10.1111/odi.12225] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/25/2013] [Revised: 01/15/2014] [Accepted: 01/22/2014] [Indexed: 11/26/2022]
Abstract
OBJECTIVES Cystic echinococcosis is a worldwide spread zoonosis and humans become accidental intermediate hosts. Any tissue can be affected. However, oromaxillofacial cystic echinococcosis is very uncommon and has never been studied systematically and no evidence-based treatment recommendations are available. Aim of this paper is to summarize the current knowledge and clinical experience with oromaxillofacial manifestations of cystic echinococcosis. MATERIALS AND METHODS PubMed database was accessed with a comprehensive, complex search strategy. Medical Subject Headings terms, wildcard search, truncated search terms and Boolean operators were used. No filters to restrict the results were set. Two evaluators jointly assessed the results in terms of defined criteria. RESULTS The search strategy retrieved 538 results in total. After evaluation 83 publications presenting 108 cases on oromaxillofacial cystic echinococcosis were included. Parotid gland, mandibular region and maxillary region were most commonly affected. Median patient age was 22 years (range 2.5 months to 81 years). Surgical treatment was performed in 97 cases. CONCLUSIONS In cases of oromaxillofacial cystic echinococcosis a thorough evaluation of the patients for further cysts is essential. Therapeutic treatment options are surgical or minimally invasive intervention and drug treatment with benzimidazoles. The diagnosis can be difficult and often require a multidisciplinary approach.
Collapse
Affiliation(s)
- Ba Just
- Department of Prosthetic Dentistry, Center of Dentistry, Ulm University Hospital, Ulm, Germany
| | | | | | | | | | | |
Collapse
|
33
|
von Minckwitz G, Kern P, Schneeweiss A, Gluz O, Harbeck N, Neumann M, Badiian M, Fries H, Rezai M. Abstract P3-14-01: Features of neoadjuvant and adjuvant chemotherapy in breast cancer – A population-based study on 39404 patients. Cancer Res 2013. [DOI: 10.1158/0008-5472.sabcs13-p3-14-01] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Neoadjuvant chemotherapy (NACT) is increasingly used globally in clinical trials for breast cancer patients. In Germany, NACT has been implemented as a standard option of care for almost a decade. In a population-based benchmark cohort study, the West German Breast Center (WBC) recorded approximately 50% of all breast cancer cases diagnosed in Germany between 2007 and 2010. We compare baseline and treatment pattern of patients treated either with adjuvant (ACT) or NACT.
Methods: Approx. 200 accredited breast centers treated 115169 primary breast cancer patients of whom 32609 received ACT and 6795 NACT. Pathological complete response (pCR) was stated if no invasive and no non-invasive tumor residues (ypT0 ypN0) were detected. Follow up information was available for 55% of patients.
Results: Use of NACT increased from 16.4% in 2007 to 19.1% in 2010 (p<.0001). Patients treated with NACT were younger, had higher clinical nodal involvement, fewer lobular-invasive cancers, more undifferentiated, hormone-receptor-negative, and HER2-positive cancers, and more multicentric tumors compared to patients treated with ACT (all p<0.002). 34% of patients in the NACT group had cT3/4 tumors compared to 7.7% of pT3/4 tumors in the ACT group. cN0 status was twice as frequent (70.6% vs 37.7%, p<.0001) whereas pN0 status was reported less frequently (47.4% vs 51.4%, p<0.0001) in the ACT and NACT group, respectively. Time between diagnosis and start of systemic treatment or surgery was in median 12 (range 1-902) and 22 (range 1-721) days in the ACT and NACT group, respectively (p<.0001). 66.2% and 91.4% of patients received ACT and NACT with a taxane, respectively (p<.0001). 9.7% and 37.5% of patients receiving treatment for > = 18 weeks, respectively. 35.2% and 69.9% of patients with HER2-positive tumors received adjuvant or neoadjuvant trastuzumab, respectively (p<.0001). 21.7% and 31.4% of patients were treated in ACT or NACT clinical trials, respectively (p<.0001). Breast conservation was possible in 69.4% and 55.2% in the ACT and NACT group, respectively (p<.0001). 30.5% and 37.5% needed two or more surgical interventions in the ACT and NACT group, respectively (p<.0001).
Multivariable logistic regression analysis confirmed taxane- and trastuzumab-based treatment, study participation, age, histologic type, grading, and hormone-receptor status as independent predictors of pCR. pCR rate was not dependent on the time between diagnosis and start of treatment or the time between end of chemotherapy and surgery.
In univariate analysis patients receiving NACT showed a 4-year overall survival rate of 78%, compared to 92% in patients receiving ACT (p<.0001). However, patients with a pCR after NACT showed a comparable survival to patients in the ACT group, whereas patients without a pCR showed a 4-year overall survival rate of 76%. In the hormone-receptor-positive/HER2-positive and even more in the triple-negative subgroup, survival of patients with a pCR appeared better than in patients with ACT.
Conclusion: In this population-based study, NACT was used in patients with unfavorable risk factors and was more intense than ACT. Outcome of patients with pCR after NACT was similar and in aggressive tumor subtypes even better than after ACT.
Citation Information: Cancer Res 2013;73(24 Suppl): Abstract nr P3-14-01.
Collapse
Affiliation(s)
- G von Minckwitz
- German Breast Group, Neu-Isenburg, Germany; Univ. Women's Hospital, Frankfurt, Germany; Breast Center Düsseldorf Luisenkrankenhaus, Düsseldorf, Germany; University Hospital of Essen, Germany; Universitätsklinikum Heidelberg, Germany; West German Study Group, Monchengladbach, Germany; Universität München, Germany; Universitätsklinikum Düsseldorf, Germany
| | - P Kern
- German Breast Group, Neu-Isenburg, Germany; Univ. Women's Hospital, Frankfurt, Germany; Breast Center Düsseldorf Luisenkrankenhaus, Düsseldorf, Germany; University Hospital of Essen, Germany; Universitätsklinikum Heidelberg, Germany; West German Study Group, Monchengladbach, Germany; Universität München, Germany; Universitätsklinikum Düsseldorf, Germany
| | - A Schneeweiss
- German Breast Group, Neu-Isenburg, Germany; Univ. Women's Hospital, Frankfurt, Germany; Breast Center Düsseldorf Luisenkrankenhaus, Düsseldorf, Germany; University Hospital of Essen, Germany; Universitätsklinikum Heidelberg, Germany; West German Study Group, Monchengladbach, Germany; Universität München, Germany; Universitätsklinikum Düsseldorf, Germany
| | - O Gluz
- German Breast Group, Neu-Isenburg, Germany; Univ. Women's Hospital, Frankfurt, Germany; Breast Center Düsseldorf Luisenkrankenhaus, Düsseldorf, Germany; University Hospital of Essen, Germany; Universitätsklinikum Heidelberg, Germany; West German Study Group, Monchengladbach, Germany; Universität München, Germany; Universitätsklinikum Düsseldorf, Germany
| | - N Harbeck
- German Breast Group, Neu-Isenburg, Germany; Univ. Women's Hospital, Frankfurt, Germany; Breast Center Düsseldorf Luisenkrankenhaus, Düsseldorf, Germany; University Hospital of Essen, Germany; Universitätsklinikum Heidelberg, Germany; West German Study Group, Monchengladbach, Germany; Universität München, Germany; Universitätsklinikum Düsseldorf, Germany
| | - M Neumann
- German Breast Group, Neu-Isenburg, Germany; Univ. Women's Hospital, Frankfurt, Germany; Breast Center Düsseldorf Luisenkrankenhaus, Düsseldorf, Germany; University Hospital of Essen, Germany; Universitätsklinikum Heidelberg, Germany; West German Study Group, Monchengladbach, Germany; Universität München, Germany; Universitätsklinikum Düsseldorf, Germany
| | - M Badiian
- German Breast Group, Neu-Isenburg, Germany; Univ. Women's Hospital, Frankfurt, Germany; Breast Center Düsseldorf Luisenkrankenhaus, Düsseldorf, Germany; University Hospital of Essen, Germany; Universitätsklinikum Heidelberg, Germany; West German Study Group, Monchengladbach, Germany; Universität München, Germany; Universitätsklinikum Düsseldorf, Germany
| | - H Fries
- German Breast Group, Neu-Isenburg, Germany; Univ. Women's Hospital, Frankfurt, Germany; Breast Center Düsseldorf Luisenkrankenhaus, Düsseldorf, Germany; University Hospital of Essen, Germany; Universitätsklinikum Heidelberg, Germany; West German Study Group, Monchengladbach, Germany; Universität München, Germany; Universitätsklinikum Düsseldorf, Germany
| | - M Rezai
- German Breast Group, Neu-Isenburg, Germany; Univ. Women's Hospital, Frankfurt, Germany; Breast Center Düsseldorf Luisenkrankenhaus, Düsseldorf, Germany; University Hospital of Essen, Germany; Universitätsklinikum Heidelberg, Germany; West German Study Group, Monchengladbach, Germany; Universität München, Germany; Universitätsklinikum Düsseldorf, Germany
| |
Collapse
|
34
|
Kern P, Rivera NR, Chandler A, Humpal M. Music Therapy Services for Individuals with Autism Spectrum Disorder: A Survey of Clinical Practices and Training Needs. J Music Ther 2013; 50:274-303. [DOI: 10.1093/jmt/50.4.274] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
35
|
Höffken G, Kern P, Buchholz U, Ewig S, Schaberg T. [Informations and recommendations of the German Respiratory Society and the Paul-Ehrlich-Society for chemotherapy concerning the outbreak of influenza A(H7N9) virus infections in humans]. Pneumologie 2013; 67:599-604. [PMID: 24154847 DOI: 10.1055/s-0033-1344807] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Abstract
In March 2013, the first cases of avian influenza virus infections in humans were reported by the authorities of the PR of China to the World Health Organization. This influenza A(H7N9) virus comprises genes of at least four different avian influenza viruses, some segments mimicking human-like influenza-signatures. Until 11 August, 2013 135 humans were infected, 44 (33%) died. The clinical course is characterized by fever, cough, gastrointestinal symptoms, lympho- and thrombopenia as well by the rapid onset of an acute respiratory distress syndrome in nearly 25% of the cases. Although human to human transmission may have occurred only in the context of three clusters, strict hygiene measures should be instituted and any suspect case should be reported to the local health authorities immediately. The detection of influenza A(H7N9) is based on real-time polymerase chain reaction (PCR). Antiviral treatment should be initiated as early as possible for suspect, probable or confirmed cases, even when 48 hours have passed after symptom onset. At present the future development of this epidemic cannot be predicted.
Collapse
Affiliation(s)
- G Höffken
- Universitätsklinikum Dresden, Fachkrankenhaus Coswig
| | | | | | | | | |
Collapse
|
36
|
Mutwiri T, Magambo J, Zeyhle E, Mkoji GM, Wamae CN, Mulinge E, Wassermann H, Kern P, Romig T. MOLECULAR CHARACTERISATION OF ECHINOCOCCUS GRANULOSUS SPECIES/STRAINS IN HUMAN INFECTIONS FROM TURKANA, KENYA. East Afr Med J 2013; 90:235-240. [PMID: 26862622] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
BACKGROUND Cystic echinococcosis (CE) or hydatid disease is a neglected, economically important zoonotic disease endemic in pastoralist communities, in particular the Turkana community of Kenya. It is caused by the larval stage of the highly diverse species complex of Echinococcusgranulosus sensu lato (s.l). The situation on the genetic diversity in humans in Kenya is not well established. OBJECTIVE To characterise Echinococcus granulosus (s.1) species/strains isolated from humans undergoing surgery in Turkana, Kenya. DESIGN A Cross sectional study. SETTING The Kakuma Mission Hospital and Centre for Microbiology Research, Kenya Medical Research Institute. SUBJECTS Eighty (80) parasite samples from 26 subjects were analysed by Polymerase chain reaction--Restriction fragment length polymorphism (PCR-RFLP) targeting the nad 1 gene for molecular characterization. RESULTS Two different genotypes of E. granulosus were identified from the samples analysed: E. granulosus sensu stricto (G1-G3) 85% of the samples analysed and E. canadensis G6/7 (15%). Most of the hydatid cysts (35%) were isolated from the liver. Other sites where cysts were isolated from include: kidney, abdomen, omentum, retroperitonium and the submandibular. Majority of cysts presented as CE1 (50%) and CE3B (42%) images according to WHO ultrasound classification. Both males and females were infected with E. granulosus s.s but only the females showed infection with E. canadensis G6/7. Chi-square test revealed significant difference between age of individuals and cysts classification by ultrasound. In addition, there was an association between cyst presentation (single or multiple) and genotype whereby all the E. canadensis G6/7 cases presented as single cysts in the infected persons. CONCLUSION This study corroborates previous reports that E. canadensis G6/7 strain is present in Turkana, a place where initially only E. granulosus s.s (G1-G3) was known to be present and that E. granulosis (G1-G3) remains the most widespread genotype infecting humans in the Turkana community.
Collapse
Affiliation(s)
- T Mutwiri
- Kenya Methodist University, School of Medicine and Health Sciences, Department of Medical Laboratory Sciences, P.O. Box 45240-00100, Nairobi, Kenya
| | | | | | | | | | | | | | | | | |
Collapse
|
37
|
Rabe E, Breu FX, Cavezzi A, Smith PC, Frullini A, Gillet JL, Guex JJ, Hamel-Desnos C, Kern P, Partsch B, Ramelet AA, Tessari L, Pannier F. European guidelines for sclerotherapy in chronic venous disorders. Phlebology 2013; 29:338-54. [DOI: 10.1177/0268355513483280] [Citation(s) in RCA: 166] [Impact Index Per Article: 15.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Aim Sclerotherapy is the targeted chemical ablation of varicose veins by intravenous injection of a liquid or foamed sclerosing drug. The treated veins may be intradermal, subcutaneous, and/or transfascial as well as superficial and deep in venous malformations. The aim of this guideline is to give evidence-based recommendations for liquid and foam sclerotherapy. Methods This guideline was drafted on behalf of 23 European Phlebological Societies during a Guideline Conference on 7–10 May 2012 in Mainz. The conference was organized by the German Society of Phlebology. These guidelines review the present state of knowledge as reflected in published medical literature. The regulatory situation of sclerosant drugs differs from country to country but this has not been considered in this document. The recommendations of this guideline are graded according to the American College of Chest Physicians Task Force recommendations on Grading Strength of Recommendations and Quality of Evidence in Clinical Guidelines. Results This guideline focuses on the two sclerosing drugs which are licensed in the majority of the European countries, polidocanol and sodium tetradecyl sulphate. Other sclerosants are not discussed in detail. The guideline gives recommendations concerning indications, contraindications, side-effects, concentrations, volumes, technique and efficacy of liquid and foam sclerotherapy of varicose veins and venous malformations.
Collapse
Affiliation(s)
- E Rabe
- Department of Dermatology, University of Bonn, Bonn, Germany
| | - FX Breu
- Practice for Vascular Medicine, Tegernsee, Germany
| | - A Cavezzi
- Vascular Unit, Poliambulatorio Hippocrates and Clinic Stella Maris, San Benedetto del Tronto (AP), Italy
| | | | - A Frullini
- Studio Medico Flebologico – Figline Valdarno, Florence, Italy
| | - JL Gillet
- Vascular Medicine and Phlebology, Bourgoin-Jallieu, France
| | - JJ Guex
- Cabinet de Phlébologie, Nice, France
| | - C Hamel-Desnos
- Department of Vascular Medicine, Saint Martin Private Hospital, Caen, France
| | - P Kern
- Private office Vevey, Service of Angiology, Lausanne University Hospital, Lausanne, Switzerland
| | | | - AA Ramelet
- Department of Dermatology, University of Bern, Switzerland
| | | | - F Pannier
- Department of Dermatology, University of Cologne, Cologne, Germany
| | | |
Collapse
|
38
|
Kaasch AJ, Rieg S, Kuetscher J, Brodt HR, Widmann T, Herrmann M, Meyer C, Welte T, Kern P, Haars U, Reuter S, Hübner I, Strauss R, Sinha B, Brunkhorst FM, Hellmich M, Fätkenheuer G, Kern WV, Seifert H. Delay in the administration of appropriate antimicrobial therapy in Staphylococcus aureus bloodstream infection: a prospective multicenter hospital-based cohort study. Infection 2013; 41:979-85. [DOI: 10.1007/s15010-013-0428-9] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/28/2013] [Accepted: 02/09/2013] [Indexed: 10/27/2022]
|
39
|
Reif P, Benedicic C, Haar K, Kern P, Laky R, Bjelic-Radisic V, Bader A, Tamussino K. Wie wurde das Endometriumkarzinom 2011 diagnostiziert? Geburtshilfe Frauenheilkd 2013. [DOI: 10.1055/s-0033-1336813] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
40
|
Barczyk A, Kern P. Scaling limits of coupled continuous time random walks and residual order statistics through marked point processes. Stoch Process Their Appl 2013. [DOI: 10.1016/j.spa.2012.10.013] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
41
|
Marques-Vidal P, Imsand D, Kayoumi A, Kern P, Mazzolai L, Depairon M. [Quality of life in patients traited for primary superficial venous insufficiency]. Praxis (Bern 1994) 2012; 101:645-650. [PMID: 22565555 DOI: 10.1024/1661-8157/a000938] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
Venous symptoms and quality of life (QOL) of 78 patients (54 women, mean age 49,5±13,3 years) with primary superficial venous insufficiency (PSVI) were compared at one year after treatment with crossectomy and stripping (C/S, 56 patients) or endovenous laser ablation (EVLA, 22 patients) using the VEINES-QOL questionnaire. Both treatments significantly (p<0,001) improved the scores for venous symptoms (difference 10,6±9,9 and 9,9±8,2 score points for C/S and EVLA, respectively) and QOL (difference 10,3±8,7 and 8,4±6,6 score points for C/S and EVLA, respectively). No difference was found between treatments regarding symptoms or QOL improvement (p=0,30). We conclude that C/S and EVLA are equally effective in improving symptoms and QOL in PSVI.
Collapse
Affiliation(s)
- P Marques-Vidal
- Institut Universitaire de Médecine Sociale et Préventive (IUMSP), Epalinges, Switzerland
| | | | | | | | | | | |
Collapse
|
42
|
Schuch F, Kern P, Kreher G, Krüger K, Wendler J, Fiehn C. [Curriculum for "Rheumatology health professionals DGRh-BDRh" as a way of qualification for clinical nursing specialists : Concept and results of an evaluation]. Z Rheumatol 2012; 70:670-7. [PMID: 21979319 DOI: 10.1007/s00393-011-0840-4] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Abstract
Rheumatological care in Germany is influenced by limited resources and education and qualification of health professionals is a way to optimize utilization of these resources.The curriculum for rheumatology health professionals of the Academy of the German Association of Rheumatologists (DGRh) was developed to qualify clinical nursing specialists of rheumatology clinics as well as specialized rheumatology hospitals on a systematic basis.Since 2006 499 participants have each been trained over 4 weekends and certification was achieved by examinations. The topics cover the principles of anatomy and the pathology of diseases up to modern diagnostic methods and treatment, including practical skills. Additional specialized courses for nurses of rheumatology hospitals and refresher courses give the participants the opportunity to increase their depth of knowledge.After 8 of the basic courses questionnaires were sent to all participants for evaluation and 143 (51%) out of 277 participants responded. Of the responders 95% found that their knowledge of understanding rheumatic diseases improved considerably or very considerably, 90% found that their ability to determine urgent cases and 86% to correctly judge emergency situations had improved and 50% agreed with the statement that their field of work and their tasks had changed after the training courses. Increased responsibilities, documentations of patient history, involvement in clinical trials and infusions and information of the patients about their disease or the treatment were listed as new tasks of the participants. In conclusion the evaluation shows that the curriculum for rheumatology health professionals is an effective step towards qualification for clinical nursing specialists. We believe that this will support the work of medical doctors in rheumatology and will improve the quality of care for patients with rheumatic diseases.
Collapse
Affiliation(s)
- F Schuch
- Praxisgemeinschaft Rheumatologie Nephrologie Erlangen, Möhrendorfer Str. 1c, 91056, Erlangen, Deutschland.
| | | | | | | | | | | |
Collapse
|
43
|
Shamoon H, Center D, Davis P, Tuchman M, Ginsberg H, Califf R, Stephens D, Mellman T, Verbalis J, Nadler L, Shekhar A, Ford D, Rizza R, Shaker R, Brady K, Murphy B, Cronstein B, Hochman J, Greenland P, Orwoll E, Sinoway L, Greenberg H, Jackson R, Coller B, Topol E, Guay-Woodford L, Runge M, Clark R, McClain D, Selker H, Lowery C, Dubinett S, Berglund L, Cooper D, Firestein G, Johnston SC, Solway J, Heubi J, Sokol R, Nelson D, Tobacman L, Rosenthal G, Aaronson L, Barohn R, Kern P, Sullivan J, Shanley T, Blazar B, Larson R, FitzGerald G, Reis S, Pearson T, Buchanan T, McPherson D, Brasier A, Toto R, Disis M, Drezner M, Bernard G, Clore J, Evanoff B, Imperato-McGinley J, Sherwin R, Pulley J. Preparedness of the CTSA's structural and scientific assets to support the mission of the National Center for Advancing Translational Sciences (NCATS). Clin Transl Sci 2012; 5:121-9. [PMID: 22507116 DOI: 10.1111/j.1752-8062.2012.00401.x] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
Abstract
The formation of the National Center for Advancing Translational Sciences (NCATS) brings new promise for moving basic science discoveries to clinical practice, ultimately improving the health of the nation. The Clinical and Translational Science Award (CTSA) sites, now housed with NCATS, are organized and prepared to support in this endeavor. The CTSAs provide a foundation for capitalizing on such promise through provision of a disease-agnostic infrastructure devoted to clinical and translational (C&T) science, maintenance of training programs designed for C&T investigators of the future, by incentivizing institutional reorganization and by cultivating institutional support.
Collapse
Affiliation(s)
-
- Albert Einstein College of Medicine (partnering with Montefi ore Medical Center)David Center
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
44
|
Ludwig T, Gaida D, Keysers C, Pinnekamp J, Bongards M, Kern P, Wolf C, Sousa Brito AL. An advanced simulation model for membrane bioreactors: development, calibration and validation. Water Sci Technol 2012; 66:1384-1391. [PMID: 22864421 DOI: 10.2166/wst.2012.249] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
Membrane wastewater treatment plants (WWTPs) have several advantages compared with conventionally designed WWTPs with classical purification techniques. The filtration process is the key to their commercial success in Germany with respect to energy consumption and effectiveness, enabled by the optimization of filtration using a dynamic simulation model. This work is focused on the development of a robust, flexible and practically applicable membrane simulation model for submerged hollow-fibre and flat-sheet membrane modules. The model is based on standard parameters usually measured on membrane WWTPs. The performance of the model is demonstrated by successful calibration and validation for three different full-scale membrane WWTPs achieving good results. Furthermore, the model is combinable with Activated Sludge Models.
Collapse
Affiliation(s)
- T Ludwig
- Cologne University of Applied Sciences, Institute of Automation and Industrial IT, Steinmuellerallee 1, 51643 Gummersbach, Germany.
| | | | | | | | | | | | | | | |
Collapse
|
45
|
Balogh N, Khoor S, Khoor M, Fugedi K, Simon I, Kern P, Florian G, Kocsis A, Kovacs I. Forecasting lethal cardiac end points of heart failure patients with low ejection fraction using refined multiscale entropy analysis. Heart 2011. [DOI: 10.1136/heartjnl-2011-300867.636] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
46
|
Kern P, Kolberg HC, Kalisch A, Liedtke C, Otterbach F, Kimmig R, Kurbacher CM. Pathologic response rate (pCR) and near-pathologic response rate (near-pCR) with docetaxel-carboplatin (TCarb) in early triple-negative breast cancer. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.27_suppl.277] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
277 Background: Triple-negative breast cancer (TNBC) is associated with a poor prognosis unless a pathological complete response is achieved (Liedtke C et al. 2008: J Clin Oncol 26:1275-1281) or almost achieved (Symmans WF. 2007: J Clin Oncol 25:4414-4422). Sensitivity to platin compounds has been demonstrated in BRCA1-positive settings (Byrski T et al. 2010: J Clin Oncol 20:28:375-9; Silver DP. 2010: J Clin Oncol 28:1145-1153) with only limited numbers of patients (Byrski T et al. 2010: J Clin Oncol 20:28:375-9) or in sporadic breast cancer with heterogeneous cohorts (Sikov WM et al 2009: J Clin Oncol 27:4693-4700; Chang HR et al. 2010: Cancer 15; 116:4227-4237). Methods: This pivotal trial was to assess the efficacy of platinum and taxane-based combination therapy without the use of anthracyclines. 27 patients with primary TNBC (majority of them cT2, two cT3 and one cT4a) had to be unsuitable for standard anthracycline-based chemotherapy. They received 6 cycles, respectively in two cases only 5 cycles, of carboplatin AUC 6 and docetaxel 75 mg/m2 q3w. The primary endpoint was the pCR-rate, secondary endpoint toxicity. Results: 20 out of 27 (74%) patients had pathological complete response (52%) or near-complete response (22%)—ypT1mic and ypT1a—both being associated with a good prognosis. Seven remaining patients had still good partial response, leaving only low residual cancer burden, which was defined as ypT1. Treatment was well-tolerated: grade III and IV toxicities were neutropenia, thrombopenia, oedema, nausea, joint pain, nail changes, fatigue, hypertension, and alopecia. Conclusions: These results show a high efficacy of carboplatin AUC6 and docetaxel 75 mg/m2 q3w and good feasibility as primary chemotherapy for TNBC with a pCR- and near-pCR-rate of 74% and total response rate of 100%. The incorporation of anthracyclines and parp-inhibitors into further trial designs could enhance the efficacy of these compounds. The omission of exposure to anthracyclines in patients with considerable heart disease risks seems to be feasible with a good pCR-rate, the latter being a surrogate-marker for long-term survival.
Collapse
Affiliation(s)
- P. Kern
- University of Duisburg-Essen, Essen, Germany; Marienhospital Bottrop, Bottrop, Germany; West German Study Group and University of Muenster, Muenster, Germany; Institute of Pathology, University of Duisburg-Essen, Essen, Germany; Department of Gynecology and Obstetrics, University of Duisburg-Essen, Essen, Germany; Medical Center Bonn-Friedensplatz, Bonn, Germany
| | - H. C. Kolberg
- University of Duisburg-Essen, Essen, Germany; Marienhospital Bottrop, Bottrop, Germany; West German Study Group and University of Muenster, Muenster, Germany; Institute of Pathology, University of Duisburg-Essen, Essen, Germany; Department of Gynecology and Obstetrics, University of Duisburg-Essen, Essen, Germany; Medical Center Bonn-Friedensplatz, Bonn, Germany
| | - A. Kalisch
- University of Duisburg-Essen, Essen, Germany; Marienhospital Bottrop, Bottrop, Germany; West German Study Group and University of Muenster, Muenster, Germany; Institute of Pathology, University of Duisburg-Essen, Essen, Germany; Department of Gynecology and Obstetrics, University of Duisburg-Essen, Essen, Germany; Medical Center Bonn-Friedensplatz, Bonn, Germany
| | - C. Liedtke
- University of Duisburg-Essen, Essen, Germany; Marienhospital Bottrop, Bottrop, Germany; West German Study Group and University of Muenster, Muenster, Germany; Institute of Pathology, University of Duisburg-Essen, Essen, Germany; Department of Gynecology and Obstetrics, University of Duisburg-Essen, Essen, Germany; Medical Center Bonn-Friedensplatz, Bonn, Germany
| | - F. Otterbach
- University of Duisburg-Essen, Essen, Germany; Marienhospital Bottrop, Bottrop, Germany; West German Study Group and University of Muenster, Muenster, Germany; Institute of Pathology, University of Duisburg-Essen, Essen, Germany; Department of Gynecology and Obstetrics, University of Duisburg-Essen, Essen, Germany; Medical Center Bonn-Friedensplatz, Bonn, Germany
| | - R. Kimmig
- University of Duisburg-Essen, Essen, Germany; Marienhospital Bottrop, Bottrop, Germany; West German Study Group and University of Muenster, Muenster, Germany; Institute of Pathology, University of Duisburg-Essen, Essen, Germany; Department of Gynecology and Obstetrics, University of Duisburg-Essen, Essen, Germany; Medical Center Bonn-Friedensplatz, Bonn, Germany
| | - C. M. Kurbacher
- University of Duisburg-Essen, Essen, Germany; Marienhospital Bottrop, Bottrop, Germany; West German Study Group and University of Muenster, Muenster, Germany; Institute of Pathology, University of Duisburg-Essen, Essen, Germany; Department of Gynecology and Obstetrics, University of Duisburg-Essen, Essen, Germany; Medical Center Bonn-Friedensplatz, Bonn, Germany
| |
Collapse
|
47
|
Romig T, Omer R, Zeyhle E, Hüttner M, Dinkel A, Siefert L, Elmahdi I, Magambo J, Ocaido M, Menezes C, Ahmed M, Mbae C, Grobusch M, Kern P. Echinococcosis in sub-Saharan Africa: Emerging complexity. Vet Parasitol 2011; 181:43-7. [DOI: 10.1016/j.vetpar.2011.04.022] [Citation(s) in RCA: 61] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
48
|
Kern P, Otterbach F, Kolberg HC, Pott D, Kalisch A, Kimmig R. Neoadjuvant platin and bevacizumab in triple-negative breast cancer. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.e11591] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
49
|
Ulrich D, Bjelic-Radisic V, Aigmüller T, Kern P, Reich O, Haar K, Bader AA, Fruhmann A, Presker-Friedrich A, Müller G, Schönett B, Prasch R, Tamussino K. Die tagesklinische Hysterektomie. Geburtshilfe Frauenheilkd 2011. [DOI: 10.1055/s-0031-1278607] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
50
|
|